Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

NCT00171990 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
February 28, 2006
Enrollment
1,461 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent genital herpes